Hikma Pharmaceuticals PLC (HKMPF)
24.50
0.00 (0.00%)
USD |
OTCM |
May 17, 16:00
Hikma Pharmaceuticals Total Assets (Quarterly): 4.68B for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 4.68B |
| June 30, 2023 | 4.619B |
| June 30, 2023 | 4.619B |
| December 31, 2022 | 4.471B |
| June 30, 2022 | 4.747B |
| June 30, 2022 | 4.747B |
| December 31, 2021 | 4.372B |
| June 30, 2021 | 4.18B |
| June 30, 2021 | 4.18B |
| December 31, 2020 | 4.135B |
| June 30, 2020 | 3.97B |
| June 30, 2020 | 3.97B |
| December 31, 2019 | 3.93B |
| June 30, 2019 | 3.606B |
| June 30, 2019 | 3.606B |
| December 31, 2018 | 3.497B |
| June 30, 2018 | 3.346B |
| June 30, 2018 | 3.346B |
| December 31, 2017 | 3.388B |
| June 30, 2017 | 4.392B |
| June 30, 2017 | 4.392B |
| December 31, 2016 | 4.363B |
| June 30, 2016 | 4.503B |
| June 30, 2016 | 4.503B |
| December 31, 2015 | 2.597B |
| Date | Value |
|---|---|
| June 30, 2015 | 2.507B |
| June 30, 2015 | 2.507B |
| December 31, 2014 | 2.251B |
| June 30, 2014 | 2.063B |
| June 30, 2014 | 2.063B |
| December 31, 2013 | 1.929B |
| June 30, 2013 | 1.733B |
| June 30, 2013 | 1.733B |
| December 31, 2012 | 1.73B |
| June 30, 2012 | 1.663B |
| June 30, 2012 | 1.663B |
| December 31, 2011 | 1.576B |
| June 30, 2011 | 1.417B |
| December 31, 2010 | 1.100B |
| June 30, 2010 | 1.068B |
| December 31, 2009 | 1.023B |
| June 30, 2009 | 1.004B |
| December 31, 2008 | 966.46M |
| June 30, 2008 | 979.71M |
| December 31, 2007 | 894.04M |
| June 30, 2007 | 607.14M |
| December 31, 2006 | 488.35M |
| June 30, 2006 | 423.16M |
| December 31, 2005 | 397.96M |
| June 30, 2005 | 294.30M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
3.606B
Minimum
Jun 2019
4.747B
Maximum
Jun 2022
4.255B
Average
4.18B
Median
Jun 2021
Total Assets (Quarterly) Benchmarks
| Adaptimmune Therapeutics PLC | 258.01M |
| Biodexa Pharmaceuticals Plc | 13.43M |
| Verona Pharma PLC | 289.91M |
| NuCana PLC | 35.43M |
| Autolus Therapeutics PLC | 375.38M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 2.471B |
| Shareholders Equity (Quarterly) | 2.198B |
| Debt to Equity Ratio | 0.5118 |
| Current Ratio | 1.568 |
| Net Debt Paydown Yield | 2.27% |